Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
73
WGS Quote, Financials, Valuation and Earnings
Last price:
$80.93
Seasonality move
:
-9.43%
Day range:
$79.15 - $82.96
52-week range:
$25.32 - $117.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.68x
P/B ratio:
8.92x
Volume:
496.2K
Avg. volume:
877.3K
1-year change:
151%
Market cap:
$2.3B
Revenue:
$305.5M
EPS (TTM):
-$1.41
Earnings Data
Next earnings date for WGS
Jul 29
2025
Most recent earnings per share
-$0.23
Missed by $0.32
(Apr 30/2025)
Consensus Estimate
$0.09
(Apr 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WGS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $93.7M | -- | -- | $0.26 | -- |
| 07/29/2025 | Q2 | $85.6M | -- | -- | $0.11 | -- |
| 04/30/2025 | Q1 | $79.8M | $87.1M | -$0.23 | $0.09 | -$0.32 |
| 02/18/2025 | Q4 | $82.2M | $95.6M | $0.23 | $0.10 | $0.13 |
| 10/29/2024 | Q3 | $65M | $76.9M | -$0.31 | -$0.22 | -$0.10 |
| 07/30/2024 | Q2 | $59.3M | $70.5M | -$1.10 | -$0.30 | -$0.80 |
| 04/29/2024 | Q1 | $49.5M | $62.4M | -$0.78 | -$0.67 | -$0.11 |
| 02/20/2024 | Q4 | $57.6M | $57.4M | -$0.92 | -$0.65 | -$0.27 |
| 10/30/2023 | Q3 | -- | -- | -$1.64 | -$1.31 | -$0.33 |
| 08/08/2023 | Q2 | -- | -- | -$1.84 | -$1.31 | -$0.53 |
| 05/09/2023 | Q1 | -- | -- | -$3.04 | -$1.48 | -$1.56 |
| 03/14/2023 | Q4 | -- | -- | -$28.97 | -$5.28 | -$23.69 |
| 11/14/2022 | Q3 | -- | -- | -$6.72 | -$5.28 | -$1.44 |
| 06/30/2022 | Q2 | -- | -- | -$8.38 | -$5.61 | -$2.77 |
| 03/31/2022 | Q1 | -- | -- | -$10.38 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$5.61 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | $5.28 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$6.34 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$26.35 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$17.27 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$7.78 | -- | -- |
GeneDx Holdings Earnings Questions
-
How Much did GeneDx Holdings Generate in Revenue Last Quarter?
GeneDx Holdings reported $87.1M worth of top line sales in its most recent quarter.
-
Did GeneDx Holdings Beat Earnings Last Quarter?
GeneDx Holdings announced earnings per share of -$0.23 which represents a miss of analyst forecast a $0.09 per share.
-
Is GeneDx Holdings Profitable?
GeneDx Holdings reported $58.5M that represents $2.08 per share over the last quarter.
-
What is the Analyst Consensus for GeneDx Holdings EPS Next Year?
GeneDx Holdings's earnings are forecast to decrease from -$1.94 per share to -$0.35 per share next year representing a decrease of -95.16%.
-
When is GeneDx Holdings's Earnings Date?
GeneDx Holdings's next earnings date is July 29, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
